Is It Safe to Take 650 mg of Paracetamol on a Regular Basis?

Sunil Kumar Kadiri, Deepika Uchil, Dhani M G, Dhritija Sathavalli, Durgesh Singh
{"title":"Is It Safe to Take 650 mg of Paracetamol on a Regular Basis?","authors":"Sunil Kumar Kadiri, Deepika Uchil, Dhani M G, Dhritija Sathavalli, Durgesh Singh","doi":"10.2174/0126667975267870231115052446","DOIUrl":null,"url":null,"abstract":"The commonest medication to treat moderate to severe pain and fever in adults and children is paracetamol and it has been observed that there has been a rapid increase in the intake of paracetamol-650 since the COVID-19 pandemic and it has continued to date. This analgesic and antipyretic medication showed an increase of 150% in its consumption during the pandemic, simultaneously escalating its self-medication. Concerns have been expressed about the indirect advertising of prescription medications, their illogical use, and improper self-medication, which has resulted in overdose and certain serious side effects. Chronic pain and pyrexia are the most common symptoms witnessed during the COVID-19 pandemic. The intake of paracetamol-650 has also been increased as a prophylactic measure due to the widespread fear generated during COVID-19. The usage of paracetamol has been shifted from 500 mg to 650 mg for mild and moderate pain and fever during and after the end of the pandemic. This raises concerns about the misuse of paracetamol-650mg which may cause damage to the liver, stomach, and kidney chronically. So, this review article aims to generate awareness among the public and physicians about the rationale of paracetamol as an analgesic and antipyretic.","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126667975267870231115052446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The commonest medication to treat moderate to severe pain and fever in adults and children is paracetamol and it has been observed that there has been a rapid increase in the intake of paracetamol-650 since the COVID-19 pandemic and it has continued to date. This analgesic and antipyretic medication showed an increase of 150% in its consumption during the pandemic, simultaneously escalating its self-medication. Concerns have been expressed about the indirect advertising of prescription medications, their illogical use, and improper self-medication, which has resulted in overdose and certain serious side effects. Chronic pain and pyrexia are the most common symptoms witnessed during the COVID-19 pandemic. The intake of paracetamol-650 has also been increased as a prophylactic measure due to the widespread fear generated during COVID-19. The usage of paracetamol has been shifted from 500 mg to 650 mg for mild and moderate pain and fever during and after the end of the pandemic. This raises concerns about the misuse of paracetamol-650mg which may cause damage to the liver, stomach, and kidney chronically. So, this review article aims to generate awareness among the public and physicians about the rationale of paracetamol as an analgesic and antipyretic.
经常服用 650 毫克扑热息痛安全吗?
治疗成人和儿童中度至重度疼痛和发烧的最常用药物是扑热息痛,据观察,自 COVID-19 大流行以来,扑热息痛-650 的摄入量迅速增加,并持续至今。在大流行期间,这种镇痛和解热药物的消费量增加了 150%,同时其自我药疗也在升级。人们对处方药的间接广告、不合逻辑的使用和不恰当的自我药疗表示担忧,这导致了用药过量和某些严重的副作用。慢性疼痛和发热是 COVID-19 大流行期间最常见的症状。由于 COVID-19 期间引发的广泛恐惧,作为预防措施,扑热息痛-650 的摄入量也有所增加。在大流行期间和结束后,用于轻度和中度疼痛和发烧的扑热息痛已从 500 毫克改为 650 毫克。这引发了人们对滥用扑热息痛-650 毫克的担忧,因为长期滥用扑热息痛-650 毫克可能会对肝、胃和肾造成损害。因此,这篇综述文章旨在提高公众和医生对扑热息痛作为镇痛药和退烧药的合理性的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信